MAIA Biotechnology, Inc. logo

MAIA Earnings Date: Nov 6, 2026 (Estimated) — MAIA Biotechnology, Inc.

AMEX

Updated

Price $1.14
Market Cap $70.4M
P/E -1.8
52W Range $0.87 – $3.19
Next Earnings · After close (est.)

When is MAIA's next earnings date?

MAIA Biotechnology, Inc. (MAIA) is expected to report Q3 2026 earnings on Friday, November 6, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.13.

How did MAIA do in its last earnings report?

In its most recent report on Aug 10, 2026 (Q2 2026), MAIA Biotechnology, Inc. posted EPS of -$0.13 versus the -$0.11 estimate, a miss of 18.2%. Revenue was $0. The stock's 1-day post-earnings move was -0.7%.

How much does MAIA stock move after earnings?

MAIA beat EPS estimates in 4 of its last 7 reported quarters. Over the last 8 reports the stock moved an average of 2.9% (up or down) in the day after earnings.

About MAIA Biotechnology, Inc.

MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-10Q2 2026-0.11-0.13-18.18%$0❌ Miss-0.70%-1.41%-7.75%
2026-05-11Q1 2026-0.18-0.14+22.22%$0✅ Beat-0.76%-4.55%-1.52%
2026-03-23Q4 2025-0.13-0.08+38.46%$0✅ Beat+2.05%-10.27%-9.59%
2025-11-07Q3 2025-0.13-0.27-107.69%$0❌ Miss+2.68%-7.14%+20.54%
2025-08-11Q2 2025-0.21-0.18+28.00%$0✅ Beat-1.97%+3.95%+4.61%
2025-03-21Q4 2024-0.35-0.12+65.71%$0✅ Beat-5.11%-7.95%+6.25%
2024-11-12Q3 2024—-0.11—$0—-8.78%-16.41%-23.28%
2024-08-09Q2 2024-0.39-0.40-2.56%$0❌ Miss+1.50%+11.28%+23.31%

Showing last 8 quarters.

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .